HDIM
BMY icon

Hanson & Doremus Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Hanson & Doremus Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
18,157
-1,370
-7% -$78.7K 0.11% 95
2026
Q1 		$1.18M Buy
19,527
+971
+5% +$56.6K 0.14% 87
2025
Q4 		$1M Buy
18,556
+1,135
+7% +$54.6K 0.12% 83
2025
Q3 		$786K Sell
17,421
-767
-4% -$35.8K 0.1% 91
2025
Q2 		$842K Sell
18,188
-709
-4% -$34.8K 0.11% 87
2025
Q1 		$1.15M Sell
18,897
-477
-2% -$27.8K 0.17% 77
2024
Q4 		$1.1M Sell
19,374
-537
-3% -$30K 0.17% 73
2024
Q3 		$1.03M Sell
19,911
-3,419
-15% -$160K 0.16% 76
2024
Q2 		$969K Sell
23,330
-6,652
-22% -$298K 0.16% 75
2024
Q1 		$1.63M Sell
29,982
-3,389
-10% -$173K 0.28% 59
2023
Q4 		$1.71M Sell
33,371
-1,866
-5% -$98K 0.32% 58
2023
Q3 		$2.04M Sell
35,237
-1,154
-3% -$70.7K 0.42% 49
2023
Q2 		$2.33M Buy
36,391
+1,342
+4% +$90K 0.48% 43
2023
Q1 		$2.43M Sell
35,049
-2,281
-6% -$161K 0.54% 38
2022
Q4 		$2.69M Buy
37,330
+3,834
+11% +$289K 0.58% 34
2022
Q3 		$2.38M Sell
33,496
-597
-2% -$43.3K 0.62% 31
2022
Q2 		$2.63M Sell
34,093
-500
-1% -$38.1K 0.64% 28
2022
Q1 		$2.53M Sell
34,593
-91
-0.3% -$6.11K 0.54% 34
2021
Q4 		$2.16M Buy
34,684
+418
+1% +$24.5K 0.46% 40
2021
Q3 		$2.03M Sell
34,266
-5,276
-13% -$347K 0.47% 42
2021
Q2 		$2.38M Buy
39,542
+2,049
+5% +$134K 0.71% 22
2021
Q1 		$2.37M Sell
37,493
-2,531
-6% -$157K 0.55% 38
2020
Q4 		$2.48M Buy
40,024
+482
+1% +$29.6K 0.62% 32
2020
Q3 		$2.38M Buy
39,542
+17
+0% +$1.02K 0.71% 22
2020
Q2 		$2.32M Sell
39,525
-2,438
-6% -$146K 0.74% 21
2020
Q1 		$2.34M Buy
41,963
+1,638
+4% +$100K 0.8% 24
2019
Q4 		$2.59M Buy
40,325
+3,297
+9% +$189K 0.74% 28
2019
Q3 		$1.88M Buy
37,028
+3,314
+10% +$156K 0.58% 39
2019
Q2 		$1.53M Buy
33,714
+348
+1% +$16.2K 0.48% 44
2019
Q1 		$1.59M Buy
33,366
+264
+0.8% +$13.2K 0.52% 44
2018
Q4 		$1.72M Sell
33,102
-589
-2% -$31.6K 0.62% 35
2018
Q3 		$2.09M Sell
33,691
-504
-1% -$29.9K 0.65% 38
2018
Q2 		$1.89M Sell
34,195
-1,837
-5% -$99.2K 0.62% 41
2018
Q1 		$2.28M Buy
36,032
+1,647
+5% +$106K 0.71% 34
2017
Q4 		$2.11M Sell
34,385
-147
-0.4% -$9.19K 0.7% 31
2017
Q3 		$2.2M Buy
34,532
+290
+0.8% +$16.9K 0.77% 31
2017
Q2 		$1.91M Buy
34,242
+1,250
+4% +$68K 0.71% 34
2017
Q1 		$1.79M Buy
32,992
+725
+2% +$39.8K 0.72% 33
2016
Q4 		$1.89M Hold
32,267
– – 0.81% 30
2016
Q3 		$1.74M Sell
32,267
-1,060
-3% -$68.1K 0.81% 33
2016
Q2 		$2.45M Sell
33,327
-100
-0.3% -$7.07K 1.11% 24
2016
Q1 		$2.13M Sell
33,427
-233
-0.7% -$14.7K 0.97% 30
2015
Q4 		$2.31M Sell
33,660
-305
-0.9% -$20.2K 1.05% 24
2015
Q3 		$2.01M Sell
33,965
-1,015
-3% -$64.4K 0.97% 30
2015
Q2 		$2.33M Buy
34,980
+450
+1% +$29.7K 0.99% 26
2015
Q1 		$2.23M Sell
34,530
-130
-0.4% -$8.14K 0.94% 32
2014
Q4 		$2.05M Buy
34,660
+1,203
+4% +$67.8K 0.88% 35
2014
Q3 		$1.71M Sell
33,457
-693
-2% -$34.6K 0.78% 38
2014
Q2 		$1.66M Sell
34,150
-50
-0.1% -$2.46K 0.76% 41
2014
Q1 		$1.78M Sell
34,200
-6,655
-16% -$354K 0.84% 35
2013
Q4 		$2.17M Sell
40,855
-1,048
-3% -$53.4K 1.04% 24
2013
Q3 		$1.94M Buy
41,903
+240
+0.6% +$10.5K 0.98% 29
2013
Q2 		$1.86M Buy
+41,663
New +$1.81M 1.02% 29

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Hanson & Doremus Investment Management's BMY Position: Q2 2026 in Review

Hanson & Doremus Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 7% in Q2 2026, selling an estimated $78.7K and leaving 18,157 shares worth $1.05M. The position accounts for 0.11% of the portfolio, ranked #95.

Hanson & Doremus Investment Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.69M in Q4 2022. 1,086 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hanson & Doremus Investment Management held 18,157 shares of Bristol-Myers Squibb worth $1.05M as of Q2 2026.
  • Hanson & Doremus Investment Management sold 1,370 Bristol-Myers Squibb shares in Q2 2026, an estimated $78.7K.
  • Bristol-Myers Squibb made up 0.11% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #95 holding.
  • Hanson & Doremus Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Hanson & Doremus Investment Management's Bristol-Myers Squibb position peaked at $2.69M in Q4 2022.
  • 1,086 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.